DONAFENIB Uses, Dosage, Side Effects and more
DONAFENIB is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated Thyroid Cancer).
| Trade Name | DONAFENIB |
| Generic | CM-4307 |
| CM-4307 Other Names | DONAFENIB |
| Type | |
| Formula | C21H16ClF3N4O3 |
| Weight | Average: 467.85 Monoisotopic: 467.1051328 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
